| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 153, Issue 2 666-674, Copyright © 1994 by American Association of Immunologists
ARTICLES |
MJ Yellin, J Sinning, LR Covey, W Sherman, JJ Lee, E Glickman-Nir, KC Sippel, J Rogers, AM Cleary and M Parker
Department of Medicine, Columbia University, College of Physicians and Surgeons, New York, NY 10032.
Activation-induced cell surface molecules are involved in mediating bidirectional T-B lymphocyte signaling that is important in the induction of T or B lymphocyte effector functions. In this regard, T- BAM/CD40-L is an activation-induced CD4+ T cell surface molecule known to be important in inducing B cell effector functions. This report demonstrates that T-BAM/CD40-L molecules on a Jurkat T cell leukemia subclone (D1.1) or nonlymphoid 293 kidney cell transfectants induce B cells or B-CLL cells to express CD80 (B7/BB-1) in a manner that is specifically inhibited by anti-T-BAM/CD40-L mAb 5C8. Because activation- induced B cell surface molecules, such as CD80, deliver costimulatory signals to T cells that augment T cell proliferation, the functional costimulatory capacity of T-BAM/CD40-L-primed B cells and B-CLL cells was studied. T-BAM/CD40-L-primed B cells or B-CLL cells augment the proliferative responses of allogenic T cells. Furthermore, T-BAM/CD40-L priming is specifically inhibited by mAb 5C8. Together, these studies demonstrate that T-BAM/CD40-L induces CD80 expression on resting B cells or B-CLL cells. Moreover, T-BAM/CD40-L signaling enhances B cell costimulatory capacity. These studies suggest that T-BAM/CD40-L molecules not only induce B cell differentiative processes that result in Ab secretion, but also enable B cells to prime Ag-specific T cells for subsequent clonal expansion.
This article has been cited by other articles:
|
|
 |
|
  A. Troeger, L. Glouchkova, B. Ackermann, G. Escherich, R. Meisel, H. Hanenberg, M. L. den Boer, R. Pieters, G. E. Janka-Schaub, U. Goebel, et al. High expression of CD40 on B-cell precursor acute lymphoblastic leukemia blasts is an independent risk factor associated with improved survival and enhanced capacity to up-regulate the death receptor CD95 Blood, August 15, 2008; 112(4): 1028 - 1034. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Waid, G. M. Vaitaitis, N. D. Pennock, and D. H. Wagner Jr Disruption of the homeostatic balance between autoaggressive (CD4+CD40+) and regulatory (CD4+CD25+FoxP3+) T cells promotes diabetes J. Leukoc. Biol., August 1, 2008; 84(2): 431 - 439. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Hamel, P. Doodes, Y. Cao, Y. Wang, J. Martinson, R. Dunn, M. R. Kehry, B. Farkas, and A. Finnegan Suppression of Proteoglycan-Induced Arthritis by Anti-CD20 B Cell Depletion Therapy Is Mediated by Reduction in Autoantibodies and CD4+ T Cell Reactivity J. Immunol., April 1, 2008; 180(7): 4994 - 5003. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. O'Neill, Y. Cao, K. M. Hamel, P. D. Doodes, G. Hutas, and A. Finnegan Expression of CD80/86 on B Cells Is Essential for Autoreactive T Cell Activation and the Development of Arthritis J. Immunol., October 15, 2007; 179(8): 5109 - 5116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Hall, M. A. Vickers, E. McLeod, and R. N. Barker Rh autoantigen presentation to helper T cells in chronic lymphocytic leukemia by malignant B cells Blood, March 1, 2005; 105(5): 2007 - 2015. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Basso, U. Klein, H. Niu, G. A. Stolovitzky, Y. Tu, A. Califano, G. Cattoretti, and R. Dalla-Favera Tracking CD40 signaling during germinal center development Blood, December 15, 2004; 104(13): 4088 - 4096. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Grube, K. Rezvani, A. Wiestner, H. Fujiwara, G. Sconocchia, J. J. Melenhorst, N. Hensel, G. E. Marti, L. W. Kwak, W. Wilson, et al. Autoreactive, Cytotoxic T Lymphocytes Specific for Peptides Derived from Normal B-Cell Differentiation Antigens in Healthy Individuals and Patients with B-Cell Malignancies Clin. Cancer Res., February 1, 2004; 10(3): 1047 - 1056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. O. Lee, J. Moyron-Quiroz, J. Rangel-Moreno, K. L. Kusser, L. Hartson, F. Sprague, F. E. Lund, and T. D. Randall CD40, but Not CD154, Expression on B Cells Is Necessary for Optimal Primary B Cell Responses J. Immunol., December 1, 2003; 171(11): 5707 - 5717. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Lumsden, J. A. Williams, and R. J. Hodes Differential Requirements for Expression of CD80/86 and CD40 on B Cells for T-Dependent Antibody Responses In Vivo J. Immunol., January 15, 2003; 170(2): 781 - 787. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Liang, E. M. Porter, and W. C. Sha Constitutive Expression of the B7h Ligand for Inducible Costimulator on Naive B Cells Is Extinguished after Activation by Distinct B Cell Receptor and Interleukin 4 Receptor-mediated Pathways and Can Be Rescued by CD40 Signaling J. Exp. Med., July 1, 2002; 196(1): 97 - 108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Krackhardt, S. Harig, M. Witzens, R. Broderick, P. Barrett, and J. G. Gribben T-cell responses against chronic lymphocytic leukemia cells: implications for immunotherapy Blood, June 17, 2002; 100(1): 167 - 173. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. G. Wierda, M. J. Cantwell, S. J. Woods, L. Z. Rassenti, C. E. Prussak, and T. J. Kipps CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia Blood, November 1, 2000; 96(9): 2917 - 2924. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Decker, F. Schneller, T. Sparwasser, T. Tretter, G. B. Lipford, H. Wagner, and C. Peschel Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells Blood, February 1, 2000; 95(3): 999 - 1006. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Rondelli, R. M. Lemoli, M. Ratta, M. Fogli, F. Re, A. Curti, M. Arpinati, and S. Tura Rapid Induction of CD40 on a Subset of Granulocyte Colony-Stimulating Factor-Mobilized CD34+ Blood Cells Identifies Myeloid Committed Progenitors and Permits Selection of Nonimmunogenic CD40- Progenitor Cells Blood, October 1, 1999; 94(7): 2293 - 2300. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Kesmir and R. J. De Boer A Mathematical Model on Germinal Center Kinetics and Termination J. Immunol., September 1, 1999; 163(5): 2463 - 2469. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Leifeld, C. Trautwein, F. L. Dumoulin, M. P. Manns, T. Sauerbruch, and U. Spengler Enhanced Expression of CD80 (B7-1), CD86 (B7-2), and CD40 and Their Ligands CD28 and CD154 in Fulminant Hepatic Failure Am. J. Pathol., June 1, 1999; 154(6): 1711 - 1720. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Suttles, D. M. Milhorn, R. W. Miller, J. C. Poe, L. M. Wahl, and R. D. Stout CD40 Signaling of Monocyte Inflammatory Cytokine Synthesis through an ERK1/2-dependent Pathway. A TARGET OF INTERLEUKIN ()-4 AND IL-10 ANTI-INFLAMMATORY ACTION J. Biol. Chem., February 26, 1999; 274(9): 5835 - 5842. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. van de Corput, H. C. Kluin-Nelemans, M. G.D. Kester, R. Willemze, and J.H. F. Falkenburg Hairy Cell Leukemia-Specific Recognition by Multiple Autologous HLA-DQ or DP-Restricted T-Cell Clones Blood, January 1, 1999; 93(1): 251 - 259. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G Cheng, A. Cleary, Z. Ye, D. Hong, S Lederman, and D Baltimore Involvement of CRAF1, a relative of TRAF, in CD40 signaling Science, March 10, 1995; 267(5203): 1494 - 1498. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
